Stage II Lung Cancer
Showing 1 - 25 of >10,000
Limited Stage Lung Small Cell Carcinoma, Stage I Lung Cancer, Stage II Lung Cancer Trial in Nashville (drug, biological,
Not yet recruiting
- Limited Stage Lung Small Cell Carcinoma
- +3 more
- Cisplatin
- +8 more
-
Nashville, TennesseeVanderbilt University/Ingram Cancer Center
Nov 10, 2023
Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8, Stage III Lung Cancer AJCC v8 Trial in Rochester (Best Practice,
Not yet recruiting
- Lung Non-Small Cell Carcinoma
- +3 more
- Best Practice
- +4 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Nov 14, 2023
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8 Trial
Recruiting
- Anatomic Stage I Breast Cancer AJCC v8
- +6 more
- Biopsy
- +3 more
-
Jacksonville, FloridaMayo Clinic in Florida
Jan 6, 2023
Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8, Stage IIA Lung Cancer AJCC v8 Trial in Los Angeles (Atezolizumab
Recruiting
- Lung Non-Small Cell Carcinoma
- +10 more
- Atezolizumab and Recombinant Human Hyaluronidase
- Survey Administration
-
Los Angeles, CaliforniaUSC / Norris Comprehensive Cancer Center
Jan 31, 2023
Lung Non-Small Cell Carcinoma, Stage I Lung Cancer AJCC v8, Stage IA1 Lung Cancer AJCC v8 Trial in Buffalo (Best Practice,
Not yet recruiting
- Lung Non-Small Cell Carcinoma
- +8 more
- Best Practice
- +2 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Dec 29, 2022
Locally Advanced Lung Non-Small Cell Carcinoma, Metastatic Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8 Trial in
Recruiting
- Locally Advanced Lung Non-Small Cell Carcinoma
- +12 more
- Computed Tomography
- Contrast Agent
-
New Brunswick, New Jersey
- +1 more
Nov 2, 2022
Lung Non-Small Cell Carcinoma, Stage I Lung Cancer AJCC v8, Stage II Lung Cancer AJCC v8 Trial (Pulmonary Artery-First Surgical
Not yet recruiting
- Lung Non-Small Cell Carcinoma
- +3 more
- Pulmonary Artery-First Surgical Technique
- Biospecimen Collection
- (no location specified)
Aug 15, 2022
Caregiver, Lung Non-Small Cell Carcinoma, Stage I Lung Cancer AJCC v8 Trial in Houston (Educational Intervention,
Recruiting
- Esophageal Carcinoma
- +16 more
- Educational Intervention
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Nov 11, 2022
Resectable Lung Non-Small Cell Carcinoma, Stage I Lung Cancer AJCC v8, Stage IA1 Lung Cancer AJCC v8 Trial in Houston
Terminated
- Resectable Lung Non-Small Cell Carcinoma
- +10 more
- Bintrafusp Alfa
- Therapeutic Conventional Surgery
-
Houston, TexasM D Anderson Cancer Center
Jul 27, 2022
Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage I Lung Cancer AJCC v8 Trial (Nivolumab,
Withdrawn
- Lung Non-Small Cell Carcinoma
- +12 more
- Nivolumab
- Sapanisertib
- (no location specified)
May 24, 2022
Stage I - II Primary Lung Cancer, Stage I Lung Cancer, Stage II Lung Cancer Trial in Boston (AveCure 16 Gauge Flexible Microwave
Not yet recruiting
- Stage I - II Primary Lung Cancer
- +5 more
- AveCure 16 Gauge Flexible Microwave Ablation Probe
-
Boston, MassachusettsBeth Israel Deaconess Medical Center
Mar 11, 2022
COPD, Lung Non-Small Cell Carcinoma, Pneumonia Trial in Buffalo (Quality-of-Life Assessment, Questionnaire Administration,
Recruiting
- Chronic Obstructive Pulmonary Disease
- +7 more
- Quality-of-Life Assessment
- +2 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Oct 20, 2022
Lung Non-Small Cell Carcinoma, Stage I Lung Cancer AJCC v8, Stage IA1 Lung Cancer AJCC v8 Trial in Atlanta (Durvalumab,
Active, not recruiting
- Lung Non-Small Cell Carcinoma
- +9 more
-
Atlanta, GeorgiaEmory University Hospital/Winship Cancer Institute
Aug 22, 2022
NSCLC Trial in Shanghai (SH-1028 tablets, Placebo SH-1028 tablets)
Recruiting
- Non-small Cell Lung Cancer
- SH-1028 tablets
- Placebo SH-1028 tablets
-
Shanghai, Shanghai, ChinaShanghai Pulmonary Hospital
Oct 6, 2023
Extensive Stage Small Cell Lung Cancer Trial (hSTC810 400 mg + Paclitaxel, hSTC810 800 mg + Paclitaxel)
Not yet recruiting
- Extensive Stage Small Cell Lung Cancer
- hSTC810 400 mg + Paclitaxel
- hSTC810 800 mg + Paclitaxel
- (no location specified)
Aug 24, 2023
Locally Advanced Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8, Stage IIA Lung Cancer AJCC v8 Trial in Columbus
Recruiting
- Locally Advanced Lung Non-Small Cell Carcinoma
- +8 more
- Carboplatin
- +4 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Apr 18, 2022
Resectable Stage II-IIIB Driver Gene-negative Non-small Cell
Not yet recruiting
- NSCLC
-
Changsha, Hunan, ChinaHunan Cancer Hospital
Aug 6, 2023
Lung Cancer, Nonsmall Cell, Lung Cancer Stage III Trial (combination product, drug, procedure, radiation)
Not yet recruiting
- Lung Cancer, Nonsmall Cell
- Lung Cancer Stage III
- Nivolumab and Chemotherapy
- +3 more
- (no location specified)
Aug 15, 2023
Nonsmall Cell Lung Cancer, Nonsmall Cell Lung Cancer, Stage II, Nonsmall Cell Lung Cancer Stage III Trial in Tampa (Genomically
Recruiting
- Nonsmall Cell Lung Cancer
- +3 more
- Genomically Guided Radiation Therapy (RT)
-
Tampa, FloridaMoffitt Cancer Center
May 23, 2023
Non-metastatic, Non-recurrent Lung and Esophageal Cancer
Recruiting
- Clinical Stage 0 Esophageal Adenocarcinoma AJCC v8
- +55 more
- Biospecimen Collection
- +3 more
-
Scottsdale, ArizonaMayo Clinic in Arizona
Jan 5, 2023
Stage I Lung Cancer AJCC v8, Stage IA1 Lung Cancer AJCC v8, Stage IA2 Lung Cancer AJCC v8 Trial in Buffalo (other, procedure,
Recruiting
- Stage I Lung Cancer AJCC v8
- +9 more
- Best Practice
- +5 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Apr 5, 2022
Lung Non-Small Cell Carcinoma, Stage I Lung Cancer AJCC v8, Stage IA1 Lung Cancer AJCC v8 Trial in New York, Houston (Best
Recruiting
- Lung Non-Small Cell Carcinoma
- +8 more
- Best Practice
- +2 more
-
New York, New York
- +1 more
Jan 18, 2022
Extensive-stage Small Cell Lung Cancer Trial in Tianjin (Selinexor,Olaparib)
Recruiting
- Extensive-stage Small Cell Lung Cancer
-
Tianjin, ChinaTianjin Medical University Cancer Institute and Hospital
Jul 27, 2023
Head and Neck Squamous Cell Carcinoma, Lung Non-Small Cell Carcinoma, Stage I Cutaneous Squamous Cell Carcinoma of the Head and
Not yet recruiting
- Head and Neck Squamous Cell Carcinoma
- +17 more
- Best Practice
- +3 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Aug 19, 2022
Bronchial Epithelial Dysplasia, COPD, Lung Carcinoma Trial in United States (procedure, drug, other)
Not yet recruiting
- Bronchial Epithelial Dysplasia
- +5 more
- Biospecimen Collection
- +5 more
-
Aurora, Colorado
- +4 more
Aug 4, 2022